Prickly Pear Health, a U.S.-based digital health company focused on women’s brain health, has expanded its pre-seed funding to more than $600,000 with a follow-on investment from Emmeline Ventures, a venture firm focused on women’s health outcomes, alongside existing investors Bayless Ventures and AZ Venture Capital.
The platform uses AI, voice analysis, and behavioral data to help women understand how hormonal fluctuations influence cognitive and emotional health – including brain fog, stress, and memory changes during hormonal transitions such as pregnancy, postpartum, perimenopause, and menopause. It combines voice data patterns with lifestyle and wearable data to deliver personalized insights supporting emotional resilience and cognitive performance.
“I founded Prickly Pear Health to address a critical blind spot in women’s healthcare: how hormonal changes impact brain health,” said founder and CEO Imen Maaroufi Clark. “This round reflects a powerful coalition of partners who believe that women deserve better tools to understand what’s happening in their brains during life transitions.”
Since its founding in 2024, the platform has surpassed 2,000 active users and plans to use the funding to accelerate growth and expand deployments with mental health practices, starting in Arizona, where the company is based..
“Prickly Pear Health represents a compelling intersection of technology, data, and an underserved market opportunity,” said Azin Radsan van Alebeek, co-founder and general partner at Emmeline Ventures.
The women’s brain health angle is an emerging niche within the broader hormonal health space – one that sits at the intersection of the cognitive symptoms women frequently report during hormonal transitions and the growing body of research linking estrogen decline to neurological changes. It’s a category that hasn’t seen much dedicated product development despite being one of the most commonly cited quality-of-life complaints across perimenopause and menopause.
